These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 24531693

  • 1. Chromatin composition alterations and the critical role of MeCP2 for epigenetic silencing of progesterone receptor-B gene in endometrial cancers.
    Chu Y, Wang Y, Zhang G, Chen H, Dowdy SC, Xiong Y, Liu F, Zhang R, Li J, Jiang SW.
    Cell Mol Life Sci; 2014 Sep; 71(17):3393-408. PubMed ID: 24531693
    [Abstract] [Full Text] [Related]

  • 2. hMLH1 promoter methylation and silencing in primary endometrial cancers are associated with specific alterations in MBDs occupancy and histone modifications.
    Xiong Y, Dowdy SC, Eberhardt NL, Podratz KC, Jiang SW.
    Gynecol Oncol; 2006 Oct; 103(1):321-8. PubMed ID: 16701802
    [Abstract] [Full Text] [Related]

  • 3. Epigenetic-mediated upregulation of progesterone receptor B gene in endometrial cancer cell lines.
    Xiong Y, Dowdy SC, Gonzalez Bosquet J, Zhao Y, Eberhardt NL, Podratz KC, Jiang SW.
    Gynecol Oncol; 2005 Oct; 99(1):135-41. PubMed ID: 16024066
    [Abstract] [Full Text] [Related]

  • 4. Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.
    Müller I, Wischnewski F, Pantel K, Schwarzenbach H.
    BMC Cancer; 2010 Jun 17; 10():297. PubMed ID: 20565761
    [Abstract] [Full Text] [Related]

  • 5. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines.
    Meng CF, Zhu XJ, Peng G, Dai DQ.
    World J Gastroenterol; 2007 Dec 14; 13(46):6166-71. PubMed ID: 18069755
    [Abstract] [Full Text] [Related]

  • 6. Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins.
    Danam RP, Howell SR, Brent TP, Harris LC.
    Mol Cancer Ther; 2005 Jan 14; 4(1):61-9. PubMed ID: 15657354
    [Abstract] [Full Text] [Related]

  • 7. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
    Zhao W, Soejima H, Higashimoto K, Nakagawachi T, Urano T, Kudo S, Matsukura S, Matsuo S, Joh K, Mukai T.
    J Biochem; 2005 Mar 14; 137(3):431-40. PubMed ID: 15809347
    [Abstract] [Full Text] [Related]

  • 8. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C.
    J Natl Cancer Inst; 2006 Mar 15; 98(6):396-406. PubMed ID: 16537832
    [Abstract] [Full Text] [Related]

  • 9. Analysis of specific lysine histone H3 and H4 acetylation and methylation status in clones of cells with a gene silenced by nickel exposure.
    Yan Y, Kluz T, Zhang P, Chen HB, Costa M.
    Toxicol Appl Pharmacol; 2003 Aug 01; 190(3):272-7. PubMed ID: 12902198
    [Abstract] [Full Text] [Related]

  • 10. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
    Magdinier F, Wolffe AP.
    Proc Natl Acad Sci U S A; 2001 Apr 24; 98(9):4990-5. PubMed ID: 11309512
    [Abstract] [Full Text] [Related]

  • 11. Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells.
    Sharma D, Blum J, Yang X, Beaulieu N, Macleod AR, Davidson NE.
    Mol Endocrinol; 2005 Jul 24; 19(7):1740-51. PubMed ID: 15746193
    [Abstract] [Full Text] [Related]

  • 12. Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells.
    Sun F, Chan E, Wu Z, Yang X, Marquez VE, Yu Q.
    Mol Cancer Ther; 2009 Dec 24; 8(12):3191-202. PubMed ID: 19934278
    [Abstract] [Full Text] [Related]

  • 13. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D, Kim KT, Scott RJ.
    BMC Cancer; 2010 Jul 12; 10():366. PubMed ID: 20618997
    [Abstract] [Full Text] [Related]

  • 14. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
    Nguyen CT, Gonzales FA, Jones PA.
    Nucleic Acids Res; 2001 Nov 15; 29(22):4598-606. PubMed ID: 11713309
    [Abstract] [Full Text] [Related]

  • 15. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
    Kim TY, Jong HS, Song SH, Dimtchev A, Jeong SJ, Lee JW, Kim TY, Kim NK, Jung M, Bang YJ.
    Oncogene; 2003 Jun 19; 22(25):3943-51. PubMed ID: 12813468
    [Abstract] [Full Text] [Related]

  • 16. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
    Meng CF, Zhu XJ, Peng G, Dai DQ.
    Oncol Rep; 2009 Nov 19; 22(5):1221-7. PubMed ID: 19787243
    [Abstract] [Full Text] [Related]

  • 17. Epigenetic silencing of TTF-1/NKX2-1 through DNA hypermethylation and histone H3 modulation in thyroid carcinomas.
    Kondo T, Nakazawa T, Ma D, Niu D, Mochizuki K, Kawasaki T, Nakamura N, Yamane T, Kobayashi M, Katoh R.
    Lab Invest; 2009 Jul 19; 89(7):791-9. PubMed ID: 19506552
    [Abstract] [Full Text] [Related]

  • 18. Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells.
    Koizume S, Tachibana K, Sekiya T, Hirohashi S, Shiraishi M.
    Nucleic Acids Res; 2002 Nov 01; 30(21):4770-80. PubMed ID: 12409468
    [Abstract] [Full Text] [Related]

  • 19. DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac.
    Liu Y, Jin X, Li Y, Ruan Y, Lu Y, Yang M, Lin D, Song P, Guo Y, Zhao S, Dong B, Xie Y, Dang Q, Quan C.
    J Exp Clin Cancer Res; 2016 Jul 26; 35(1):120. PubMed ID: 27461117
    [Abstract] [Full Text] [Related]

  • 20. Epigenetic regulation of gelsolin expression in human breast cancer cells.
    Mielnicki LM, Ying AM, Head KL, Asch HL, Asch BB.
    Exp Cell Res; 1999 May 25; 249(1):161-76. PubMed ID: 10328963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.